Royalty Pharma plc Business Finance Contracts & Agreements

37 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment and Restatement Agreement to Exchange Agreement among Royalty Pharma Entities and Shareholders (May 2025)
Exchange Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2025
Joinder, Release, and First Amendment to Loan Agreement among RP Management, Royalty Pharma Entities, and Bank of America
Loan Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2025
Amendment No. 1 to Membership Interests Purchase Agreement among Royalty Pharma Holdings Ltd., Royalty Pharma PLC, and Seller Representative
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
2025
Description of Class A Ordinary Shares Registered Under Section 12 of the Securities Exchange Act of 1934 by Royalty Pharma plc
Equity Distribution Agreements
Royalty Pharma plc
Pharmaceuticals
2025
Membership Interests Purchase Agreement among Royalty Pharma, LLC, RP Management, LLC, Sellers, and Royalty Pharma Holdings Ltd.
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
DC
2025
Amendment and Restatement Agreement to Exchange Agreement among Royalty Pharma Entities (December 31, 2024)
Exchange Agreements
Royalty Pharma plc
Pharmaceuticals
DE
2024
Third Supplemental Indenture to Indenture Dated September 2, 2020 among Royalty Pharma plc, Royalty Pharma Holdings Ltd, and Wilmington Trust, National Association (5.150% Senior...
Indenture Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2024
Underwriting Agreement for $1.5 Billion Senior Unsecured Notes of Royalty Pharma plc (2029, 2034, 2054)
Underwriting Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2024
Description of Class A Ordinary Shares Registered Under Section 12 of the Securities Exchange Act of 1934 by Royalty Pharma plc
Equity Distribution Agreements
Royalty Pharma plc
Pharmaceuticals
2024
Amendment No. 3 to Credit Agreement among Royalty Pharma PLC, Royalty Pharma Holdings Ltd., and Bank of America, N.A.
Credit Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2023
Description of Registered Securities of Royalty Pharma plc under Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Royalty Pharma plc
Pharmaceuticals
2023
Description of Registered Securities of Royalty Pharma plc under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Royalty Pharma plc
Pharmaceuticals
2022
Second Supplemental Indenture to Indenture Dated September 2, 2020 among Royalty Pharma plc, Royalty Pharma Holdings Ltd., and Wilmington Trust, National Association
Indenture Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2021
Underwriting Agreement for $1.3 Billion Senior Unsecured Notes between Royalty Pharma plc and Underwriters
Underwriting Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2021
Description of Registered Securities of Royalty Pharma plc under Section 12 of the Securities Exchange Act of 1934
Equity Distribution Agreements
Royalty Pharma plc
Pharmaceuticals
2021
Amendment No. 2 to Amended and Restated Purchase and Sale Agreement among Cystic Fibrosis Foundation, RPI Finance Trust, and RPI 2019 Intermediate Finance Trust
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Registration Rights Agreement among Royalty Pharma plc, Initial Guarantor, and Initial Purchasers (September 2, 2020)
Registration Rights Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
First Supplemental Indenture to Senior Notes between Royalty Pharma plc, Royalty Pharma Holdings Ltd., and Wilmington Trust, N.A.
Indenture Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Indenture Agreement among Royalty Pharma plc, Royalty Pharma Holdings Ltd., and Wilmington Trust, N.A. dated September 2, 2020
Indenture Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Amendment No. 1 to Amended and Restated Purchase and Sale Agreement between Cystic Fibrosis Foundation Therapeutics, Inc. and RPI Finance Trust
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Amended and Restated Purchase and Sale Agreement between Cystic Fibrosis Foundation Therapeutics, Inc. and RPI Finance Trust
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
DE
2020
Registration Rights Agreement among Royalty Pharma plc and Certain Security Holders (June 18, 2020)
Registration Rights Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Exchange Agreement among Royalty Pharma PLC, Royalty Pharma Holdings Limited, and RPI Partnerships (June 16, 2020)
Exchange Agreements
Royalty Pharma plc
Pharmaceuticals
DE
2020
Royalty Pharma plc Class A Ordinary Share Certificate Issued to Mr. Alexander David Sample
Stock Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Underwriting Agreement for Sale of Class A Ordinary Shares of Royalty Pharma plc by Selling Shareholders to Underwriters
Underwriting Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Registration Rights Agreement among Royalty Pharma plc, Initial Guarantor, and Initial Purchasers (September 2, 2020)
Registration Rights Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
First Supplemental Indenture to Indenture Dated September 2, 2020 Among Royalty Pharma plc, Royalty Pharma Holdings Ltd., and Wilmington Trust, N.A.
Indenture Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Indenture Agreement among Royalty Pharma plc, Royalty Pharma Holdings Ltd., and Wilmington Trust, National Association (2020)
Indenture Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Registration Rights Agreement among Royalty Pharma plc and Certain Security Holders (June 18, 2020)
Registration Rights Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Exchange Agreement among Royalty Pharma PLC, Royalty Pharma Holdings Limited, and RPI Partnerships (June 16, 2020)
Exchange Agreements
Royalty Pharma plc
Pharmaceuticals
DE
2020
Royalty Pharma plc Class A Ordinary Share Certificate Issued to Mr. Alexander David Sample
Stock Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Underwriting Agreement for Class A Ordinary Shares of Royalty Pharma plc with Multiple Underwriters
Underwriting Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Amendment No. 1 to Amended and Restated Purchase and Sale Agreement between Cystic Fibrosis Foundation Therapeutics, Inc. and RPI Finance Trust
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
2020
Amended and Restated Purchase and Sale Agreement between Cystic Fibrosis Foundation Therapeutics, Inc. and RPI Finance Trust (November 14, 2014)
Purchase Agreements
Royalty Pharma plc
Pharmaceuticals
DE
2020
Registration Rights Agreement among Royalty Pharma plc and Certain Security Holders (2020)
Registration Rights Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020
Exchange Agreement among Royalty Pharma PLC, Royalty Pharma Holdings Limited, and RPI Partnerships
Exchange Agreements
Royalty Pharma plc
Pharmaceuticals
DE
2020
$6,040,000,000 Credit Agreement among RPI 2019 Intermediate Finance Trust and Lenders, dated February 11, 2020
Credit Agreements
Royalty Pharma plc
Pharmaceuticals
NY
2020